Medtronic suffered a cyberattack on its corporate IT systems. The incident highlights growing cybersecurity risks in the medtech sector, with cybergangs increasingly using phishing and other human-engineering tactics to gain access to data.

The post 6 Things to Know About Medtronic’s Cyberattack appeared first on MedCity News.

Jennifer Thompson, Medtronic’s vice president of U.S. aortic sales, detailed how AI is transforming medical device commercialization during a fireside chat at Reuters’ MedTech conference. The technology is helping teams identify patients, optimize their sales deployment and discover care bottlenecks.

The post Medtronic Exec: AI Is Improving Device Launches & Patient Outcomes appeared first on MedCity News.

UCSF researcher Maria Shcherbakova highlighted how adaptive deep brain stimulation is improving Parkinson’s care by automatically adjusting brain implants in real time to better control symptoms.

The post How Medtronic & UCSF Are Giving Parkinson’s Patients Greater Control Over Their Symptoms appeared first on MedCity News.

September has seen a wide range of executive hires, exits, promotions and layoffs across the healthcare industry. For example, Medtronic, Amgen and Kaiser Permanente welcomed new executives. There were also layoffs at organizations including Novo Nordisk and Seattle Children’s.

The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News.

Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit more room to focus and compete in its own crowded market.

The post Why Is Medtronic Spinning Off Its Diabetes Business? appeared first on MedCity News.

Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers.

The post Orchestra BioMed’s Hypertension Device Wins FDA Breakthrough Designation appeared first on MedCity News.

January has seen a slew of executive hires, promotions and layoffs across the healthcare industry. For example, health tech companies like Medtronic and athenahealth hired new C-suite leaders, and providers like Cleveland Clinic and Jefferson Health announced rounds of job cuts.

The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News.

A Beverly Hills surgeon has sued Medtronic, alleging that the medical device giant stole her design for a hernia mesh device. One lawyer pointed out that this is not a typical patent infringement case.

The post Medtronic-Hexagon Health Lawsuit Highlights the Struggle Between Doctors & Industry appeared first on MedCity News.

Over the past decade, Abbott and Dexcom — the two largest makers of continuous glucose monitors — have been teaming up with medical device companies that sell automated insulin delivery systems. Industry experts think these partnerships are smart moves to stay relevant in the rapidly-developing diabetes care space.

The post The Surprising Rivalries-Turned-Friendships That Are Shaping Diabetes Technology appeared first on MedCity News.

Abbott and Medtronic — typically regarded as competitors — have recently joined forces. The two companies teamed up to collaborate on a continuous glucose monitoring system that combines Abbott’s FreeStyle Libre technology with Medtronic’s automated insulin delivery system.

The post When Foes Become Friends: Abbott Teams Up With Medtronic appeared first on MedCity News.

During a panel discussion on GLP-1s at the Abarca Forward conference, one health executive stressed the importance of a food-as-medicine approach.

The post Health Exec: Food-as-Medicine Will Change How Healthcare Is Delivered With or Without GLP-1s appeared first on MedCity News.

Geoff Martha sought to establish a clear line between popular understanding of AI created by apps like ChatGPT and what he believes is the significant impact that Medtronic’s AI-enabled products are already having on patients and other healthcare stakeholders today.

The post Medtronic CEO On the Company’s AI: This Isn’t About ChatGPT appeared first on MedCity News.

Gastroenterologist Dr. Austin Chiang has about a decade of experience as a physician influencer on social media. During a conference in Chicago, he encouraged more providers to share their expertise on social media. By having a presence on these platforms, healthcare professionals demonstrate their commitment to meeting patients where they are, he said.

The post Should More Doctors Be on TikTok? This One Says Yes appeared first on MedCity News.

Allurion Technologies has commercialized a gastric balloon in the form of a pill that patients swallow. But the weight loss platform from the now NYSE-listed company also includes AI-driven software that provides insights about a patient’s progress, technology with the potential for use alongside obesity drugs.

The post Newly Public Allurion Aims to Show How Med Tech Can Complement Obesity Drugs appeared first on MedCity News.

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes. The news comes two years after Medtronic submitted the system for FDA approval and three years after the company began selling the product in Europe.

The post Medtronic Gains FDA Approval for Newest Insulin Pump appeared first on MedCity News.

Nvidia and Medtronic recently announced a collaboration focused on embedding AI into medical devices. The two companies plan to create marketplace for AI applications that will allow developers and clinicians to develop their own algorithms to use on Medtronic’s medical devices.

The post Nvidia, Medtronic Partner to Create AI Platform for Medical Devices appeared first on MedCity News.

Allurion Technologies has developed a gastric balloon that does not require surgery. The merger deal taking Allurion public comes as the company continues global commercialization of its technology.

The post Weight Loss in a Pill Device Firm Allurion Heads to NYSE via SPAC Merger appeared first on MedCity News.

Abbott recently earned FDA approval for its latest transcatheter aortic valve implantation (TAVI) system, which is named Navitor. Abbott will have to fight for its place the U.S. TAVI device space, as the systems made by Edwards and Medtronic have a steadfast command of the market share.

The post Abbott Enters TAVI Device Market Dominated by Edwards, Medtronic appeared first on MedCity News.

The innovation platform promises to match entrepreneurs with the resources they need to advance treatments for stroke care but also to help the device maker process all the new ideas it sees.

The post Medtronic serves up platform for stroke-care startups appeared first on MedCity News.

Mike Matson evaluated two earlier negative bits of information along with Thursday’s revenue and earnings-per-share miss to conclude that Medtronic’s stock, which has held up despite recent market swings, needs to be downgraded to a “hold” from a “buy”.

The post Skeptical of future performance, spooked by recent misses, Needham analyst downgrades Medtronic’s stock appeared first on MedCity News.

[Sponsored] An infographic illustrates how Medtronic’s AccuRhythm AI suppresses false alerts while maintaining sensitivity.

The post Using AI to reduce false alerts for patients with heart monitoring devices to detect cardiac arrhythmias appeared first on MedCity News.

To get approval for the deal, Medtronic agreed to sell an Intersect subsidiary to soothe the FTC’s concerns.

The post With the FTC’s conditional approval, Medtronic completes its $1.1B acquisition of Intersect ENT appeared first on MedCity News.

Geoff Martha participated in the 40th annual J.P. Morgan Healthcare conference virtually explaining key decisions, accepting responsibility for a trifecta of bad news while also signaling that all will be well in the future at the Dublin-based medtech giant.

The post Key takeaways from Medtronic CEO’s presentation at virtual JPM conference appeared first on MedCity News.

The company received a warning letter on Wednesday related to inadequate quality requirements at the headquarters for its diabetes business. It comes after Medtronic expanded a recall of its MiniMed 600 series insulin pumps.

The post Medtronic hit with FDA warning letter for diabetes devices appeared first on MedCity News.

Medtronic is expanding a recall of two of its MiniMed 600 series insulin pumps after reports found several had broken retainer rings cracked, resulting in insulin doses that were too high or too low. 

The post Medtronic expands recall of MiniMed insulin pumps  appeared first on MedCity News.

Investors had long expected Intersect ENT to be an acquisition target before Medtronic announced its plans to buy the company last week. Better reimbursement for Intersect ENT’s products and elective procedures returning over the summer months might have helped the deal cross the finish line. 

The post Why Medtronic decided to move now on its $1.1B Intersect ENT deal  appeared first on MedCity News.

[Sponsored] Join our live webinar with top MedTech sales experts to learn how to succeed in the digital revolution of medical device and healthcare sales.

The post How to lead a digital transformation in healthcare sales [live webinar] appeared first on MedCity News.

Medtronic suffered a shocking setback back in 2014 when its Symplicity 3 pivotal trial failed to meet its primary endpoint of reducing blood pressure meaningfully. Now it is gearing up to present new data to the FDA.

The post Medtronic CEO expects to submit renal denervation data to FDA this year, overcoming previous failures appeared first on MedCity News.

With a recent acquisition from France, Medtronic is aiming to leverage AI in the world of spine surgery and integrate the system with its robot.

The post With AI, 3D imaging and a robot, Medtronic Spine aims to leave competitors bent out of shape appeared first on MedCity News.

In a public health crisis such as the Covid-19 pandemic, each healthcare vertical is playing a crucial role. Diagnostics companies are racing to test in the most accurate way possible, biotech and pharma companies are moving mountains to quickly develop vaccines and study potential therapies, while digital health companies have stepped up to the plate […]

The post How medtech companies are fighting Covid-19? appeared first on MedCity News.